Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea-Reference-Cited by-同舟云学术

Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea

Published:2019-12-17 Issue:1 Volume:98 Page:149-159
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Lindner Andreas U.,Resler Alexa J.,Carberry Steven,Oficjalska Kasia,Bacon Orna,Lee Chun Seng,Choudhry Abdurehman,Burke John P.,Sheahan Kieran,Cremona Mattia,Hennessy Bryan T,McNamara Deborah,Doherty Glen,Ryan Elizabeth J.,Prehn Jochen H.M.^ORCID

Funder

Science Foundation Ireland

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-019-01864-z.pdf

Reference49 articles.

1. Tilson L, Sharp L, Usher C, Walsh C, Whyte S, O’Ceilleachair A, Stuart C, Mehigan B, John Kennedy M, Tappenden P, Chilcott J, Staines A, Comber H, Barry M (2012) Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ 13(4):511–524

2. Zalcberg J, Kerr D, Seymour L, Palmer M (1998) Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group. Eur J Cancer 34(12):1871–1875

3. Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA, Pazdur R (2004) FDA drug approval summaries: oxaliplatin. Oncologist 9(1):8–12

4. Arbuckle RB, Huber SL, Zacker C (2000) The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist 5(3):250–259

5. National Cancer Institute USDoHaHS (2017) Common Terminology Criteria for Adverse Events (CTCAE). 5.0:146

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the First-in-Class Fxr/Ces2 Dual Modulator Le-77 for the Treatment of Irinotecan-Induced Delayed Diarrhea;2024

2. Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis;Biochemical Pharmacology;2023-09

3. Distinct diarrhea profiles during outpatient chemotherapy;Supportive Care in Cancer;2020-09-12